Arvin Cyrus Arman - Sep 20, 2022 Form 4 Insider Report for CytoDyn Inc. (CYDY)

Role
President
Signature
/s/ Antonio Migliarese, Attorney-In-Fact
Stock symbol
CYDY
Transactions as of
Sep 20, 2022
Transactions value $
$0
Form type
4
Date filed
9/22/2022, 08:20 PM
Previous filing
Jul 21, 2022
Next filing
Feb 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CYDY Common Stock Award $0 +647K $0.00 647K Sep 20, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CYDY Non-qualified stock option (right to buy) Award $0 +1.58M $0.00 1.58M Sep 20, 2022 Common Stock 1.58M $0.58 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2012 Equity Incentive Plan, as amended (the "Plan"). The RSUs will vest in four (4) equal annual installments beginning July 9, 2023, subject to Continuous Service (as the term is defined in the Plan) through the applicable vesting date.
F2 25% of the award will vest on July 9, 2023; thereafter, the balance will vest in 36 equal monthly installments, subject to Continuous Service (as the term is defined in the Plan) through the applicable vesting date.